Cargando…
SUN-417 Recovery Of Central Adrenal Insufficiency In A Patient With Hypophysitis Secondary To Immune Checkpoint Inhibitors Therapy
Hypophysitis is a well-recognized immune-related adverse event that occurs in approximately 16% of patients treated with immune checkpoint inhibitors (ICIs), particularly the anti-cytotoxic T-lymphocyte associated antigen (CTLA4) monoclonal antibody, ipilimumab. While the synthesis and secretion of...
Autores principales: | Thapi, Sahityasri, Leiter, Amanda, Galsky, Matthew, Gallagher, Emily |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552875/ http://dx.doi.org/10.1210/js.2019-SUN-417 |
Ejemplares similares
-
Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis
por: Thapi, Sahityasri, et al.
Publicado: (2019) -
SUN-298 Spectrum of Imaging in Immune Checkpoint Inhibitor Induced Hypophysitis
por: Quandt, Zoe, et al.
Publicado: (2020) -
SUN-437 Central Adrenal Insufficiency Unmasked by Pregnancy
por: Araque, Katherine, et al.
Publicado: (2019) -
THU092 Characterizing Immune Checkpoint Inhibitor Induced Hypophysitis In A Large Urban Health Care System
por: Gogerly-Moragoda, Mahalya, et al.
Publicado: (2023) -
SUN-307 Partial Secondary Adrenal Insufficiency and Growth Hormone Deficiency in Fibromyalgia
por: Gruber, Lucinda, et al.
Publicado: (2020)